-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
-
Summary
-
GT Biopharma, Inc. quarterly/annual Operating Lease, Payments history and growth rate from Q1 2022 to Q1 2024.
- GT Biopharma, Inc. Operating Lease, Payments for the quarter ending March 31, 2024 was $30.000.
- GT Biopharma, Inc. annual Operating Lease, Payments for 2023 was $118K, a 8.26% increase from 2022.
- GT Biopharma, Inc. annual Operating Lease, Payments for 2022 was $109K.
- GT Biopharma, Inc. annual Operating Lease, Payments for 2020 was $0.000, a 100% decline from 2019.
Operating Lease, Payments, Quarterly (USD)